The recent announcement of the resurrection of the dire wolf generated considerable global media attention and widespread ...

Not since DDT was introduced to U.S. agriculture to kill insects after World War Two has a farm chemical been as important to ...

Phase 3 clinical trial of BNC-210 in social anxiety disorder on track for topline readout in Q3 2025α7 nicotinic ...

Viking Therapeutics offers leaner operations, lower complexity, faster trial execution, and less execution risk. Learn more ...

Market OverviewBreast cancer remains one of the most prevalent forms of cancer worldwide, affecting millions of individuals ...

Vigil's shareholders to receive up to $10.00 per share in cash, comprised of $8.00 per share in cash at closing and a ...

SAN FRANCISCO, May 19, 2025 (GLOBE NEWSWIRE) -- 23andMe Holding Co. ("23andMe” or the "Company”) (OTC: MEHCQ), a leading ...

Randee’s cancer had metastasized. When her doctor tested her for the PIK3CA gene mutation, she was able to make informed ...

Phase 3 clinical trial of BNC-210 in social anxiety disorder on track for topline readout in Q3 2025a7 nicotinic acetylcholine receptor PAM MK-1167 partnered with Merck ...

Insmed Incorporated , a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases, presented 11 ...

FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 240+ patents issued and pending with a focus on the development of therapeutics and potential cures ...

Rydex Biotechnology Fund earns a Below Average ... It's difficult to say what the long-term effects of losing a leader could be for any organization, but ‎inherent in Minerd's design was a ...